Prophylaxis for neonatal group B streptococcus infections
- 1 February 1998
- journal article
- review article
- Published by Elsevier in Seminars in Perinatology
- Vol. 22 (1) , 33-49
- https://doi.org/10.1016/s0146-0005(98)80006-2
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.Journal of Clinical Investigation, 1996
- Early-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research NetworkThe Journal of Pediatrics, 1996
- Structural and Immunochemical Characterization of the Type VIII Group B Streptococcus Capsular PolysaccharideJournal of Biological Chemistry, 1996
- Invasive Group B Streptococcal Disease: The Emergence of Serotype VThe Journal of Infectious Diseases, 1996
- Identification of cpsD, a gene essential for type III capsule expression in group B streptococciMolecular Microbiology, 1993
- A ten-year review of neonatal sepsis and comparison with the previous fifty-year experienceThe Pediatric Infectious Disease Journal, 1990
- Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.Proceedings of the National Academy of Sciences, 1989
- Immunization of Pregnant Women with a Polysaccharide Vaccine of Group B StreptococcusNew England Journal of Medicine, 1988
- Correlation of Maternal Antibody Deficiency with Susceptibility to Neonatal Group B Streptococcal InfectionNew England Journal of Medicine, 1976
- Neonatal Sepsis and Other Infections Due to Group B Beta-Hemolytic StreptococciNew England Journal of Medicine, 1964